NCT00668772View on ClinicalTrials.gov

Tiotropium/Salmeterol Inhalation Powder in COPD

PHASE3TerminatedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

April 15, 2008

Primary Completion Date

November 21, 2008

Study Completion Date

November 21, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium/Salmeterol

Tiotropium/Salmeterol Inhalation Powder, Hard Polyethylene Capsule

DRUG

Tiotropium/Salmeterol QD + Salmeterol

Tiotropium/Salmeterol Inhalation Powder, Hard Polyethylene Capsule, plus Salmeterol Inhalation Powder, hard PE capsule

DRUG

Placebo

Placebo Inhalation Powder, hard PE capsule / hard gelatine capsule

DRUG

Salmeterol

Salmeterol Inhalation Powder, hard PE capsule

DRUG

Tiotropium

Tiotropium Inhalation Powder, hard gelatine capsule (Spiriva®)

Trial Locations (64)

Unknown

1184.15.01069 Boehringer Ingelheim Investigational Site, Anniston

1184.15.01071 Boehringer Ingelheim Investigational Site, Mobile

1184.15.01054 Boehringer Ingelheim Investigational Site, Clearwater

1184.15.01063 Boehringer Ingelheim Investigational Site, Tampa

1184.15.01064 Boehringer Ingelheim Investigational Site, Tampa

1184.15.01065 Boehringer Ingelheim Investigational Site, Savannah

1184.15.01052 Boehringer Ingelheim Investigational Site, New Orleans

1184.15.01055 Boehringer Ingelheim Investigational Site, St Louis

1184.15.01058 Boehringer Ingelheim Investigational Site, St Louis

1184.15.01062 Boehringer Ingelheim Investigational Site, St Louis

1184.15.01072 Boehringer Ingelheim Investigational Site, Summit

1184.15.01053 Boehringer Ingelheim Investigational Site, Albuquerque

1184.15.01070 Boehringer Ingelheim Investigational Site, New York

1184.15.01057 Boehringer Ingelheim Investigational Site, Elizabeth City

1184.15.01059 Boehringer Ingelheim Investigational Site, Charleston

1184.15.01051 Boehringer Ingelheim Investigational Site, Morgantown

1184.15.43052 Boehringer Ingelheim Investigational Site, Gänserndorf

1184.15.43053 Boehringer Ingelheim Investigational Site, Vienna

1184.15.02057 Boehringer Ingelheim Investigational Site, Vancouver

1184.15.02059 Boehringer Ingelheim Investigational Site, Vancouver

1184.15.02055 Boehringer Ingelheim Investigational Site, Hamilton

1184.15.02058 Boehringer Ingelheim Investigational Site, Ottawa

1184.15.02051 Boehringer Ingelheim Investigational Site, Scarborough Village

1184.15.02053 Boehringer Ingelheim Investigational Site, Toronto

1184.15.02060 Boehringer Ingelheim Investigational Site, Longueuil

1184.15.02056 Boehringer Ingelheim Investigational Site, Montreal

1184.15.45054 Boehringer Ingelheim Investigational Site, Aalborg

1184.15.45052 Boehringer Ingelheim Investigational Site, Kolding

1184.15.45051 Boehringer Ingelheim Investigational Site, Odense C

1184.15.45053 Boehringer Ingelheim Investigational Site, Silkeborg

1184.15.37252 Boehringer Ingelheim Investigational Site, Kohtla-Järve

1184.15.37251 Boehringer Ingelheim Investigational Site, Tallinn

1184.15.35852 Boehringer Ingelheim Investigational Site, Oulu

1184.15.35851 Boehringer Ingelheim Investigational Site, Tampere

1184.15.3350A Boehringer Ingelheim Investigational Site, Marseille

1184.15.3351A Boehringer Ingelheim Investigational Site, Nantes

1184.15.3352A Boehringer Ingelheim Investigational Site, Paris

1184.15.49056 Boehringer Ingelheim Investigational Site, Aschaffenburg

1184.15.49053 Boehringer Ingelheim Investigational Site, Frankfurt

1184.15.49057 Boehringer Ingelheim Investigational Site, Gelnhausen

1184.15.49052 Boehringer Ingelheim Investigational Site, Hanover

1184.15.49058 Boehringer Ingelheim Investigational Site, Hanover

1184.15.36055 Boehringer Ingelheim Investigational Site, Deszk

1184.15.36053 Boehringer Ingelheim Investigational Site, Érd

1184.15.36054 Boehringer Ingelheim Investigational Site, Szarvas

1184.15.36052 Boehringer Ingelheim Investigational Site, Szeged

1184.15.39051 Boehringer Ingelheim Investigational Site, Florence

1184.15.37154 Boehringer Ingelheim Investigational Site, Balvi

1184.15.37152 Boehringer Ingelheim Investigational Site, Jelgava

1184.15.37153 Boehringer Ingelheim Investigational Site, Tukums

1184.15.37053 Boehringer Ingelheim Investigational Site, Klaipėda

1184.15.31051 Boehringer Ingelheim Investigational Site, Breda

1184.15.31054 Boehringer Ingelheim Investigational Site, Utrecht

1184.15.31052 Boehringer Ingelheim Investigational Site, Zutphen

1184.15.42153 Boehringer Ingelheim Investigational Site, Bratislava

1184.15.42154 Boehringer Ingelheim Investigational Site, Bratislava

1184.15.27051, Bellville

1184.15.27052, Cape Town

1184.15.27053, Somerset West

1184.15.82051 Boehringer Ingelheim Investigational Site, Jeonju

1184.15.82052 Boehringer Ingelheim Investigational Site, Suwon

1184.15.82053 Boehringer Ingelheim Investigational Site, Wŏnju

1184.15.46053 Boehringer Ingelheim Investigational Site, Boden

1184.15.46051 Boehringer Ingelheim Investigational Site, Stockholm

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY